Multimeric Epitope-Scaffold HIV Vaccines Target V1V2 and Differentially Tune Polyfunctional Antibody Responses
Open Access
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 28 (4) , 877-895.e6
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 114 references indexed in Scilit:
- Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2Nature, 2012
- Subunit organization of the membrane-bound HIV-1 envelope glycoprotein trimerNature Structural & Molecular Biology, 2012
- Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individualsVirology, 2012
- Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeysNature, 2012
- Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9Nature, 2011
- Broad neutralization coverage of HIV by multiple highly potent antibodiesNature, 2011
- Structural Analysis of Human and Macaque mAbs 2909 and 2.5B: Implications for the Configuration of the Quaternary Neutralizing Epitope of HIV-1 gp120Structure, 2011
- Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffoldVirology, 2010
- Structure–function relationships of HIV-1 envelope sequence-variable regions refocus vaccine designNature Reviews Immunology, 2010
- Follicular dendritic cell networks of primary follicles and germinal centers: Phenotype and functionSeminars in Immunology, 2008